Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening.
Ikonen TS, Gummert JF, Serkova N, Hayase M, Honda Y, Kobayase Y, Hausen B, Yock PG, Christians U, Morris RE. Ikonen TS, et al. Among authors: gummert jf. Transpl Int. 2000;13 Suppl 1:S314-20. doi: 10.1007/s001470050351. Transpl Int. 2000. PMID: 11112022
Development of models of graft vascular disease in nonhuman primates: evaluation of GVD by intravascular ultrasound in a new cynomolgus model with arterial allograft exchange.
Ikonen TS, Gummert JF, Honda Y, Hayase M, Perlroth J, Hausen B, Barlow C, Fitzgerald P, Yock PG, Morris RE. Ikonen TS, et al. Among authors: gummert jf. Transplant Proc. 1999 Feb-Mar;31(1-2):687. doi: 10.1016/s0041-1345(98)01609-1. Transplant Proc. 1999. PMID: 10083296 Free article. No abstract available.
Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
Hausen B, Gummert J, Berry GJ, Christians U, Serkova N, Ikonen T, Hook L, Legay F, Schuler W, Schreier MH, Morris RE. Hausen B, et al. Transplantation. 2000 Feb 27;69(4):488-96. doi: 10.1097/00007890-200002270-00005. Transplantation. 2000. PMID: 10708100
A new large-animal model for research of graft vascular disease.
Gummert JF, Ikonen T, Briffa N, Honda Y, Hayase M, Perlroth J, Kobayashi Y, Hausen B, Barlow C, Billingham ME, Fitzgerald P, Yock PG, Robbins RC, Morris RE. Gummert JF, et al. Transplant Proc. 1998 Dec;30(8):4023. doi: 10.1016/s0041-1345(98)01327-x. Transplant Proc. 1998. PMID: 9865284 Free article. No abstract available.
Newer immunosuppressive drugs: a review.
Gummert JF, Ikonen T, Morris RE. Gummert JF, et al. J Am Soc Nephrol. 1999 Jun;10(6):1366-80. doi: 10.1681/ASN.V1061366. J Am Soc Nephrol. 1999. PMID: 10361877 Review.
276 results